Flamel Technologies (FLML)
Create an AlertFLML Key Stats
| Income Statement | |
| Revenue TTM | 26.10M |
| Revenue Quarterly YoY Growth | -15.48% |
| EPS Diluted TTM | -0.139 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -3.228M |
| Profitability | |
| Gross Profit Margin Quarterly | 79.55% |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 153.52M |
| Enterprise Value | 181.24M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 5.033 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 1.201 |
| Free Cash Flow | |
| Return on Equity | |
FLML News
- Flamel Technologies Announces Product Partnership Agreement Marketwired Jun 6
- Nasdaq stocks posting largest volume increases Jun 4
- Nasdaq stocks posting largest percentage increases Jun 4
- Flamel Tech rises to annual high on drug approval Jun 3
- Flamel (FLMML) Bloxiverz NDA Approved by U.S. FDA Street Insider Jun 3
- Flamel Technologies Announces FDA Approval of Bloxiverz Marketwired Jun 3
- Nasdaq stocks posting largest percentage increases May 29
- Flamel Technologies Obtains Rights to Two Molecules of Trigger Lock Product Line Marketwired May 23
- Flamel Technologies S.A. Shares Cross Below 200 DMA May 9
- Flamel Technologies' CEO Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha May 7
FLML Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Flamel Technologies is up 50.00% over the last year vs S&P 500 Total Return up 23.89%, ACADIA Pharmaceuticals up 1082%, and Albany Molecular Research up 348.9%.
FLML Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these FLML related companies
Pro Ratings for FLML
Pro Report PDF for FLML
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download FLML Pro Report PDF
Pro Strategies Featuring FLML
Did Flamel Technologies make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
FLML Profile
Sector: Healthcare
Industry: Biotechnology
Other FLML Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| FLML | 6.15 | -0.01 | -0.16% | 153.52M |
